Associate Chief Physician, Associate Professor, with over 30 years of experience in the profession
Affiliated HospitalSouthern Medical University Southern Hospital
→
Research areas : Breast augmentation (breast reduction, breast reconstruction); facial plastic surgery; correction of congenital malformations.
Cutting-edge technology: various types of breast augmentation and reconstruction; repair of congenital cleft lip and palate, microtia, hypospadias; repair of burn/traumatic deformities and defects.
Specializes in treating: breast deformities/defects, congenital cleft lip and palate, microtia, and scar contracture deformities.
Academic Highlights: Over 30 years of experience in plastic and cosmetic surgery; recipient of one second-class and five third-class awards for military scientific and technological achievements; co-author of "Cosmetic Surgery" and "Trauma and Repair".
Liu Qifa
Level 2 Professor, Chief Physician, Doctoral Supervisor, Academic Leader, Director of the Institute of Hematology
Research areas : Molecular pathogenesis of leukemia, hematopoietic stem cell transplantation, tumor immunotherapy, and prevention and treatment of infections in immunocompromised hosts.
- Cutting-edge technologies: Haploidentical hematopoietic stem cell transplantation; MICM precision stratification therapy for leukemia; precision stratification therapy for acute leukemia (rewriting the NCCN/ELN guidelines); combined haploidentical and umbilical cord blood transplantation (Lancet RCT); MSC prevention of GVHD (earliest in China); sorafenib treatment for post-transplant AML (one of the top ten advances in Chinese hematology).
- Areas of expertise: Acute leukemia, aplastic anemia, refractory and relapsed hematological malignancies, refractory leukemia, lymphoma/myeloma, and hematological diseases requiring hematopoietic stem cell transplantation.
- Academic Highlights & Value: National Outstanding Physician (202), Vice Chairman of the Hematology Branch of the Chinese Medical Association, Head of the Infectious Diseases Group, Member of the Asia-Pacific Society of Hematology; presided over 3 National Key Research and Development Programs, 3 National Key Research and Development Programs, and 10 National Natural Science Foundation of China projects (including major/key projects); won 1 second prize of the National Science and Technology Progress Award and 3 first prizes at the provincial and ministerial levels; published more than 300 papers; twice selected as one of the Top Ten Research Advances in Hematology in China. Proposed a genetic stratification treatment strategy for leukemia to improve the long-term survival rate of patients, and the results have been incorporated into domestic guidelines.
Feng Ru
Professor, Chief Physician, Doctoral Supervisor, Deputy Director of Department, Head of Lymphoma Subspecialty
-Research areas : pathogenesis, diagnosis and treatment of lymphoma and multiple myeloma, targeted immunotherapy, and leukemia.
- Cutting-edge technologies: Dynamic monitoring of MRD for lymphoma and myeloma, and clinical research on new drugs for relapsed and refractory lymphomas.
- Areas of expertise: Hodgkin's/non-Hodgkin's lymphoma, multiple myeloma, plasma cell diseases, lymphoma, leukemia.
- Academic Highlights & Value: Visiting scholar experience in the United States and Japan; presided over multiple National Natural Science Foundation of China projects; published research findings in international journals such as Blood and PNAS; led clinical trials of new drugs for lymphoma and myeloma. Head of the lymphoma subspecialty, with high expertise in the precise diagnosis, subtyping, and targeted therapy of lymphoma/myeloma.
Sun Jing
Professor, Chief Physician, Doctoral Supervisor, Deputy Director of Department, Director of Hemophilia Center
-Research areas : Hematopoietic stem cell transplantation, bleeding disorders, and hemophilia diagnosis and treatment
- Cutting-edge technologies: unrelated hematopoietic stem cell transplantation, hemophilia inhibitor immune tolerance induction program/comprehensive diagnosis and treatment of hemophilia and inhibitor management (the largest hemophilia center in South China), prevention and treatment of transplant complications.
- Areas of expertise: Hemophilia, von Willebrand disease, platelet disorders, and transplantation treatment for various malignant hematological diseases.
- Academic Highlights & Value: Member of the Hemostasis and Thrombosis Group of the Hematology Branch of the Chinese Medical Association; completed over 2500 transplants; founder of the South China Hemophilia Diagnosis and Treatment System; training expert for the World Federation of Hemophilia. Core expert in hemophilia diagnosis and treatment management; participated in the development of international standards (Haemophilia 201) and domestic expert consensus.